Cor Vasa 2026, 68(3):330-339

Pacing induced cardiomyopathy and upgrade to cardiac resynchronization therapy

Jakub Šimka, Jan Vojáček, Petr Pařízek
First Department of Internal Medicine, Cardiology and Angiology, University Hospital Hradec Kralove and Charles University, Faculty of Medicine in Hradec Kralove, Hradec Kralove, the Czech Republic

Upgrade to cardiac resynchronization therapy is an established method to treat patients with a permanent pacemaker or implantable cardioverter-defibrillator who develop symptoms of heart failure and left ventricular dysfunction. Pacing induced cardiomyopathy represents a potentially reversible cause of left ventricular dysfunction that can fully recover after implantation of biventricular pacing or conduction system pacing.

Keywords: Biventricular pacing, Cardiac resynchronization therapy, Conduction system pacing, Heart failure, Pacing induced cardiomyopathy, Upgrade

Received: October 16, 2025; Revised: February 8, 2026; Accepted: February 10, 2026; Prepublished online: June 2, 2012; Published: July 1, 2026  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Šimka J, Vojáček J, Pařízek P. Pacing induced cardiomyopathy and upgrade to cardiac resynchronization therapy. Cor Vasa. 2026;68(3):330-339.
Download citation

References

  1. Táborský M, Kautzner J, Fedorco M, et al. 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. Translation of the document prepared by the Czech Society of Cardiology. Cor Vasa 2022;64(Suppl.2):7-86.
  2. Bulava A, Hájek P, Kautzner J, et al. Cardiac resynchronization therapy in the Czech Republic - Data from the EHRA CRT Survey II multicenter registry. Cor Vasa 2018;60:e622-e630.
  3. Somma V, Ha FJ, Palmer S, et al. Pacing-induced cardiomyopathy: A systematic review and meta-analysis of definition, prevalence, risk factors, and management. Heart Rhythm 2023;20:282-290. Go to original source...
  4. Khurshid S, Obeng-Gyimah E, Supple GE, et al. Reversal of Pacing-Induced Cardiomyopathy Following Cardiac Resynchronization Therapy. JACC: Clin Electrophysiol 2018;4:168-177. Go to original source...
  5. Kaye G, Ng JY, Ahmed S, Valencia D, et al. The Prevalence of Pacing-Induced Cardiomyopathy (PICM) in Patients With Long Term Right Ventricular Pacing - Is it a Matter Of Definition? Heart, Lung and Circulation 2019;28:1027-1033.
  6. Li DL, Yoneda ZT, Issa TZ, et al. Prevalence and predictors of pacing-induced cardiomyopathy in young adult patients (
  7. Khurshid S, Epstein AE, Verdino RJ, et al. Incidence and predictors of right ventricular pacing-induced cardiomyopathy. Heart Rhythm. 2014;11:1619-1625. Go to original source...
  8. Rosenqvist M, Brandt J, Schüller H. Long-term pacing in sinus node disease: Effects of stimulation mode on cardiovascular morbidity and mortality. Am Heart J 1988;116:16-22. Go to original source...
  9. Andersen HR, Nielsen JC, Thomsen PEB, et al. Long-term follow-up of patients from a randomised trial of atrial versus ventricular pacing for sick-sinus syndrome. The Lancet 1997;350:1210-1216.
  10. Nielsen JC, Andersen HR, Thomsen PEB, et al. Heart Failure and Echocardiographic Changes During Long-term Follow-up of Patients With Sick Sinus Syndrome Randomized to Single-Chamber Atrial or Ventricular Pacing. Circulation 1998;97:987-995.
  11. Lamas GA, Lee KL, Sweeney MO, et al. Ventricular Pacing or Dual-Chamber Pacing for Sinus-Node Dysfunction. N Engl J Med 2002;346:1854-1862.
  12. Sweeney MO, Hellkamp AS, Ellenbogen KA, et al. Adverse Effect of Ventricular Pacing on Heart Failure and Atrial Fibrillation Among Patients With Normal Baseline QRS Duration in a Clinical Trial of Pacemaker Therapy for Sinus Node Dysfunction. Circulation 2003;107:2932-2937.
  13. The DAVID Trial Investigators. Dual-Chamber Pacing or Ventricular Backup Pacing in Patients With an Implantable Defibrillator: The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. JAMA.2002;288:3115. Go to original source...
  14. Moss AJ, Zareba W, Hall WJ, et al. Prophylactic Implantation of a Defibrillator in Patients with Myocardial Infarction and Reduced Ejection Fraction. N Engl J Med 2002;346:877-883.
  15. Steinberg JS, Fischer A, Wang P, et al. The Clinical Implications of Cumulative Right Ventricular Pacing in the Multicenter Automatic Defibrillator Trial II. J Cardiovasc Electrophysiol 2005;16:359-365.
  16. Sweeney MO, Hellkamp AS. Heart Failure During Cardiac Pacing. Circulation 2006;113:2082-2088.
  17. Tops LF, Schalij MJ, Bax JJ. The Effects of Right Ventricular Apical Pacing on Ventricular Function and Dyssynchrony. J Am Coll Cardiol 2009;54:764-776. Go to original source...
  18. Prinzen FW, Peschar M. Relation Between the Pacing Induced Sequence of Activation and Left Ventricular Pump Function in Animals. Pacing Clin Electrophysiol 2002;25:484-498. Go to original source...
  19. Vijayaraman P, Bordachar P, Ellenbogen KA. The Continued Search for Physiological Pacing. J Am Coll Cardiol 2017;69:3099-3114.
  20. Ahmed FZ, Khattar RS, Zaidi AM, et al. Pacing-induced cardiomyopathy: pathophysiological insights through matrix metalloproteinases. Heart Fail Rev 2014;19:669-680.
  21. Merchant FM, Mittal S. Pacing induced cardiomyopathy. J Cardiovasc Electrophysiol 2020;31:286-292. Go to original source...
  22. Leclercq C, Gras D, Le Helloco A, et al. Hemodynamic importance of preserving the normal sequence of ventricular activation in permanent cardiac pacing. Am Heart J 1995;129:1133-1141.
  23. Stojnic BB, Stojanov PL, Angelkov L, et al. Evaluation of Asynchronous Left Ventricular Relaxation by Doppler Echocardiography During Ventricular Pacing with AV Synchrony (VDD): Comparison with Atrial Pacing (AAI). Pacing Clin Electrophysiol 1996;19:940-944.
  24. Zile MR, Blaustein AS, Shimizu G, Gaasch WH. Right ventricular pacing reduces the rate of left ventricular relaxation and filling. J Am Coll Cardiol 1987;10:702-709. Go to original source...
  25. Bedotto JB, Grayburn PA, Black WH, et al. Alterations in left ventricular relaxation during atrioventricular pacing in humans. J Am Coll Cardiol 1990;15:658-664. Go to original source...
  26. Gorcsan J, Lumens J. Rocking and Flashing With RV Pacing. JACC: Cardiovasc Imaging 2017;10:1100-1102.
  27. Stankovic I, Prinz C, Ciarka A, et al. Long-Term Outcome After CRT in the Presence of Mechanical Dyssynchrony Seen With Chronic RV Pacing or Intrinsic LBBB. J Am Coll Cardiol: Cardiovasc Imaging 2017;10:1091-1099.
  28. Fanari Z, Hammami S, Hammami MB, et al. The effects of right ventricular apical pacing with transvenous pacemaker and implantable cardioverter defibrillator on mitral and tricuspid regurgitation. J Electrocardiol 2015;48:791-797.
  29. Dilaveris P, Pantazis A, Giannopoulos G, et al. Upgrade to biventricular pacing in patients with pacing-induced heart failure: can resynchronization do the trick? EP Europace. 2006;8:352-357.
  30. Saito M, Iannaccone A, Kaye G, et al. Effect of Right Ventricular Pacing on Right Ventricular Mechanics and Tricuspid Regurgitation in Patients With High-Grade Atrioventricular Block and Sinus Rhythm (from the Protection of Left Ventricular Function During Right Ventricular Pacing Study). Am J Cardiol 2015;116:1875-1882.
  31. Kim S, Cho K, Cha T, et al. Left Atrial Responses to Acute Right Ventricular Apical Pacing in Patients with Sick Sinus Syndrome. Echocardiography 2013;30:1042-1050. Go to original source...
  32. Nielsen JC, Kristensen L, Andersen HR, et al. A randomized comparison of atrial and dual-chamber pacing in177 consecutive patients with sick sinus syndrome. J Am Coll Cardiol 2003;42:614-623. Go to original source...
  33. Lamas GA, Orav EJ, Stambler BS, et al. Quality of Life and Clinical Outcomes in Elderly Patients Treated with Ventricular Pacing as Compared with Dual-Chamber Pacing. N Engl J Med 1998;338:1097-1104. Go to original source...
  34. Chan NY, Yuen HC, Choy CC, et al. Left Ventricular Volumes and Systolic Function After Long-term Right Ventricular Pacing May be Predicted by Paced QRS Duration, but not Pacing Site. Heart, Lung, Circ 2014;23:43-48. Go to original source...
  35. Shimony A, Eisenberg MJ, Filion KB, Amit G. Beneficial effects of right ventricular non-apical vs. apical pacing: a systematic review and meta-analysis of randomized-controlled trials. Europace 2012;14:81-91. Go to original source...
  36. Kaye GC, Linker NJ, Marwick TH, et al. Effect of right ventricular pacing lead site on left ventricular function in patients with high-grade atrioventricular block: results of the Protect-Pace study. Eur Heart J 2015;36:856-862.
  37. Janoušek J, van Geldorp IE, Krupičková S, et al. Permanent Cardiac Pacing in Children: Choosing the Optimal Pacing Site: A Multicenter Study. Circulation 2013;127:613-623. Go to original source...
  38. Kiehl EL, Makki T, Kumar R, et al. Incidence and predictors of right ventricular pacing-induced cardiomyopathy in patients with complete atrioventricular block and preserved left ventricular systolic function. Heart Rhythm 2016;13:2272-2278. Go to original source...
  39. Kaza N, Htun V, Miyazawa A, et al. Upgrading right ventricular pacemakers to biventricular pacing or conduction system pacing: a systematic review and meta-analysis. EP Europace 2022 Nov 10;euac188.
  40. Lu W, Lin J, Dai Y, Chen K, Zhang S. The therapeutic effects of upgrade to cardiac resynchronization therapy in pacing-induced cardiomyopathy or chronic right ventricular pacing patients: a meta-analysis. Heart Fail Rev 2022;27:507-516. Go to original source...
  41. Vallsbertault V. Assessment of upgrading to biventricular pacing in patients with right ventricular pacing and congestive heart failure after atrioventricular junctional ablation for chronic atrial fibrillation. Europace 2004;6:438-443. Go to original source...
  42. Höijer CJ, Meurling C, Brandt J. Upgrade to biventricular pacing in patients with conventional pacemakers and heart failure: a double-blind, randomized crossover study. EP Europace 2006;8:51-55.
  43. Merkely B, Hatala R, Wranicz JK, et al. Upgrade of right ventricular pacing to cardiac resynchronization therapy in heart failure: a randomized trial. Eur Heart J 2023;44:4259-4269.
  44. Merkely B, Hatala R, Merkel E, et al. Benefits of upgrading right ventricular to biventricular pacing in heart failure patients with atrial fibrillation. Europace 2024;26:euae179. Go to original source...
  45. Linde CM, Normand C, Bogale N, et al. Upgrades from a previous device compared to de novo cardiac resynchronization therapy in the European Society of Cardiology CRT Survey II: Upgrade vs. de novo CRT implantation. Eur J Heart Fail 2018;20:1457-1468. Go to original source...
  46. Trenson S, Voros G, Martens P, et al. Long-term outcome after upgrade to cardiac resynchronization therapy: A propensity score-matched analysis. Eur J Heart Fail 2024;26:511-520.
  47. Rickard J, Gorodeski EZ, Patel D, et al. Long term outcomes in patients with chronic right ventricular pacing upgraded to cardiac resynchronization therapy. Cardiovasc Electrophysiol 2019;30:1979-1983.
  48. Kosztin A, Vamos M, Aradi D, et al. De novo implantation vs. upgrade cardiac resynchronization therapy: a systematic review and meta-analysis. Heart Fail Rev 2018;23:15-26. Go to original source...
  49. Peichl P, Bulava A, Toman O, Kautzner J. (2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death). Cor Vasa 2023;65:186-235.
  50. Leyva F, Zegard A, Patel K, et al. Clinical outcomes after upgrading from pacemakers to cardiac resynchronization therapy. Pacing Clin Electrophysiol 2018;41:290-298. Go to original source...
  51. Barra S, Duehmke R, Providencia R, et al. Patients upgraded to cardiac resynchronization therapy due to pacing-induced cardiomyopathy are at low risk of life-threatening ventricular arrhythmias: a long-term cause-of-death analysis. EP Europace 2018;20:89-96.
  52. Kawamura M, Arai S, Yoshikawa K, et al. Association left ventricular lead and ventricular arrhythmias after upgrade to cardiac resynchronization therapy in patients with implantable cardioverter defibrillators. Clin Cardiol 2019;42:670-677.
  53. Abdelrahman M, Subzposh FA, Beer D, et al. Clinical Outcomes of His Bundle Pacing Compared to Right Ventricular Pacing. J Am Coll Cardiol 2018;71:2319-2330. Go to original source...
  54. Catanzariti D, Maines M, Manica A, et al. Permanent His-bundle pacing maintains long-term ventricular synchrony and left ventricular performance, unlike conventional right ventricular apical pacing. Europace 2013;15:546-553. Go to original source...
  55. Sharma PS, Patel NR, Ravi V, et al. Clinical outcomes of left bundle branch area pacing compared to right ventricular pacing: Results from the Geisinger-Rush Conduction System Pacing Registry. Heart Rhythm 2022;19:3-11.
  56. Vijayaraman P, Herweg B, Dandamudi G, et al. Outcomes of His-bundle pacing upgrade after long-term right ventricular pacing and/or pacing-induced cardiomyopathy: Insights into disease progression. Heart Rhythm 2019;16:1554-1561. Go to original source...
  57. Huang W, Su L, Wu S, et al. A Novel Pacing Strategy With Low and Stable Output: Pacing the Left Bundle Branch Immediately Beyond the Conduction Block. Can J Cardiol 2017;33:1736.e1-1736.e3. Go to original source...
  58. Bressi E, Grieco D, Luermans J, et al. Conduction system pacing for cardiac resynchronization therapy: State of the art, current controversies, and future perspectives. Front Physiol 2023;14:1124195.
  59. Vijayaraman P, Ponnusamy S, Cano Ó, et al. Left Bundle Branch Area Pacing for Cardiac Resynchronization Therapy. JACC: Clinical Electrophysiol 2021;7:135-147. Go to original source...
  60. Qian Z, Wang Y, Hou X, et al. Efficacy of upgrading to left bundle branch pacing in patients with heart failure after right ventricular pacing. Pacing Clin Electrophysiol 2021;44:472-480. Go to original source...
  61. Rademakers LM, Bouwmeester S, Mast TP, et al. Feasibility, safety and outcomes of upgrading to left bundle branch pacing in patients with right ventricular pacing induced cardiomyopathy. Pacing Clin Electrophysiol 2022;45:726-732.
  62. Shan Y, Lin M, Sun Y, et al. The specific value of upgrading to left bundle branch area pacing in patients with pacing-induced cardiomyopathy or non-pacing-induced cardiomyopathy related upgrade status: A retrospective study. Pacing Clin Electrophysiol 2023;46:761-770.
  63. Huang H, Li X, Long T, et al. Effectiveness of upgrade left bundle branch area pacing for right ventricular pacing-induced cardiomyopathy: Extra QRS shortening matters. J Arrhyth 2025;41:e70017.
  64. Shahab A, Lacy S, Chandler JK, et al. Cardiac resynchronization therapy for pacing induced cardiomyopathy: Role of baseline right ventricular pacing burden. Pacing Clin Electrophysiol 2024;47:336-341. Go to original source...
  65. Davy JM, Hoffmann E, Frey A, et al. Near Elimination of Ventricular Pacing in SafeR Mode Compared to DDD Modes: A Randomized Study of 422 Patients: VENTRICULAR PACING REDUCTION IN SAFER MODE. Pacing Clin Electrophysiol 2012;35:392-402. Go to original source...
  66. Boriani G, Tukkie R, Manolis AS, et al. Atrial antitachycardia pacing and managed ventricular pacing in bradycardia patients with paroxysmal or persistent atrial tachyarrhythmias: the MINERVA randomized multicentre international trial. Eur Heart J 2014;35:2352-2362. Go to original source...
  67. Yadav R, Jaswal A, Chennapragada S, et al. Effectiveness of Ventricular Intrinsic Preference (VIPTM) and Ventricular AutoCapture (VAC) algorithms in pacemaker patients: Results of the validate study. J Arrhyth 2016;32:29-35. Go to original source...
  68. Strik M, Defaye P, Eschalier R, et al. Performance of a specific algorithm to minimize right ventricular pacing: A multicenter study. Heart Rhythm 2016;13:1266-1273. Go to original source...
  69. Shurrab M, Healey JS, Haj-Yahia S, et al. Reduction in unnecessary ventricular pacing fails to affect hard clinical outcomes in patients with preserved left ventricular function: a meta-analysis. Europace 2016 Oct 26;euw221.
  70. Botto LG, Ricci RP, Bénézet JM, et al. Managed ventricular pacing compared with conventional dual-chamber pacing for elective replacement in chronically paced patients: Results of the Prefer for Elective Replacement Managed Ventricular Pacing randomized study. Heart Rhythm 2014;11:992-1000. Go to original source...
  71. Kindermann M, Hennen B, Jung J, et al. Biventricular Versus Conventional Right Ventricular Stimulation for Patients With Standard Pacing Indication and Left Ventricular Dysfunction. J Am Coll Cardiol 2006;47:1927-1937. Go to original source...
  72. Curtis AB, Worley SJ, Chung ES, et al. Improvement in Clinical Outcomes With Biventricular Versus Right Ventricular Pacing. J Am Coll Cardiol 2016;67:2148-2157. Go to original source...
  73. Funck RC, Mueller HH, Lunati M, et al. Characteristics of a large sample of candidates for permanent ventricular pacing included in the Biventricular Pacing for Atrio-ventricular Block to Prevent Cardiac Desynchronization Study (BioPace). EP Europace 2014;16:354-362.
  74. Vijayaraman P, Mathew AJ, Naperkowski A, et al. Conduction system pacing versus conventional pacing in patients undergoing atrioventricular node ablation: Nonrandomized, on-treatment comparison. Heart Rhythm O2 2022;3:368-376.
  75. Pillai A, Kolominsky J, Koneru JN, et al. Atrioventricular junction ablation in patients with conduction system pacing leads: A comparison of His-bundle vs left bundle branch area pacing leads. Heart Rhythm 2022;19:1116-1123. Go to original source...
  76. Stankovic I, Prinz C, Ciarka A, et al. Relationship of visually assessed apical rocking and septal flash to response and long-term survival following cardiac resynchronization therapy (PREDICT-CRT). Eur Heart J Cardiovasc Imaging 2016;17: 262-269. Go to original source...
  77. Tayal B, Gorcsan J, Delgado-Montero A, et al. Comparative long-term outcomes after cardiac resynchronization therapy in right ventricular paced patients versus native wide left bundle branch block patients. Heart Rhythm 2016;13:511-518.
  78. Kosiuk J, Krause M, Doering M, et al. Outcome in patients undergoing upgrade to cardiac resynchronization therapy: predictors of outcome after upgrade to CRT. Heart Vessels 2020;35:104-109.
  79. Loboda D, Gibinski M, Zietek K, et al. Survival of patients with pacing-induced cardiomyopathy upgraded to CRT does not depend on defibrillation therapy. Pacing Clin Electrophysiol 2020;43:471-478. Go to original source...
  80. Nazeri A, Massumi A, Rasekh A, et al. Cardiac Resynchronization Therapy in Patients with Right Ventricular Pacing-Induced Cardiomyopathy. Pacing Clin Electrophysiol 2010;33:37-40. Go to original source...
  81. Gwag HB, Chun KJ, Hwang JK, et al. Comparison of De Novo versus Upgrade Cardiac Resynchronization Therapy; Focused on the Upgrade for Pacing-Induced Cardiomyopathy. Yonsei Med J 2017;58:703. Go to original source...
  82. Rath B, Willy K, Wolfes J, et al. Predictors of response to cardiac resynchronization therapy in patients with chronic right ventricular pacing. Clin Res Cardiol 2021;110:877-883.
  83. Cheung JW, Ip JE, Markowitz SM, et al. Trends and outcomes of cardiac resynchronization therapy upgrade procedures: A comparative analysis using a United States National Database 2003-2013. Heart Rhythm 2017;14:1043-1050. Go to original source...
  84. Poole JE, Gleva MJ, Mela T, et al. Complication Rates Associated With Pacemaker or Implantable Cardioverter-Defibrillator Generator Replacements and Upgrade Procedures: Results From the REPLACE Registry. Circulation 2010;122:1553-1561.
  85. Dickstein K, Normand C, Auricchio A, et al. CRT Survey II: a European Society of Cardiology survey of cardiac resynchronisation therapy in 11 088 patients-who is doing what to whom and how? Eur J Heart Fail 2018;20:1039-1051.
  86. Kirkfeldt RE, Johansen JB, Nohr EA, et al. Complications after cardiac implantable electronic device implantations: an analysis of a complete, nationwide cohort in Denmark. Eur Heart J 2014;35:1186-1194. Go to original source...
  87. Boriani G, Diemberger I. Cardiac resynchronization therapy in the real world: need to upgrade outcome research. Eur J Heart Fail 2018;20:1469-1471. Go to original source...

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.